Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group was honored with a lifetime achievement award in recognition of his exemplary services in the nutraceuticals and cosmeceuticals industry by ASSOCHAM (The Associated Chambers of Commerce and Industry of India). The award was presented as part of Ayush Mela, one of India’s largest exhibition and conference events related to Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy (AYUSH).
Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
- Details
- Press Release
- 1417
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group has recently published the fourth book in a series on derivatives of Boswellia serrata.
Sabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
- Details
- Press Release
- 1638
Sabinsa, a pioneer in the nutraceutical and cosmeceutical industry, has provided documentation to appropriate government agencies in its continuing efforts to identify and remove adulterated vitamin C additives from the market, a practice to which Sabinsa alerted the industry earlier this year.
Sabinsa Providing Glyphosate Test Results with Ingredients
- Details
- Press Release
- 1440
Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, is offering glyphosate test results to customers, using a proprietary method for testing glyphosate developed by scientists at parent company Sami-Sabinsa. In October they began testing for residual herbicide in 20 nutraceutical ingredients as a routine practice, along with all other USP listed pesticides, and are widening the scope to all products the company sells. Spices must be below 7 ppm and herbs below 0.2 ppm.
Sabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
- Details
- Press Release
- 1415
Sabinsa, a pioneer in the nutraceutical and cosmeceutical industries, has expanded its large portfolio of intellectual property with a new patent granted in Mexico for the company’s Boswellia serrata ingredient Boswellin® PS.
Sabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
- Details
- Press Release
- 1433
Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, has strengthened its market position in Canada with the grant of three new patents. The company has also received an additional Natural Products Number (NPN) issued by Health Canada, bringing their total number of products with health claims in Canada to 37.
Dr. Majeed Foundation Distributes 5,500 Rice Bags to Needy Communities in Karnataka, India
- Details
- Press Release
- 1354
Disruptions from the COVID-19 pandemic have caused hardship across the world, with the poorest people in India hit particularly hard. With the objective of helping to alleviate food insecurity, the Dr. Majeed Foundation gave 5,500 rice bags of 10 kilo each to the people of Magadi, Karnataka on September 24, 2020. The Foundation is the philanthropic organization started and funded by the Sami-Sabinsa Group founder and chairman, Dr. Muhammed Majeed.
Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
- Details
- Press Release
- 1395
Sabinsa, the leading nutraceutical ingredients company with patents throughout the world, has expanded its portfolio of intellectual property with a new patent granted in Mexico for Saberry®.
Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
- Details
- Press Release
- 1307
A clinical study on Sabinsa’s patented hair serum formulation was found to significantly improve hair fall and thinning. “Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall” by Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P and Shah K was published in Clinical, Cosmetic and Investigational Dermatology (2020:13 691–700).
Research on Sabinsa’s Cosmeceutical LactoSporin® Showing Anti-Acne Benefits among the First Published Human Clinical Studies Examining a Probiotic Metabolite
- Details
- Press Release
- 1465
Additional In Vitro Study Examined Anti-Aging Properties
As Sabinsa’s R&D Scientists expanded their understanding of probiotics, and developed new products based upon that increased knowledge, it was inevitable that published studies would soon follow. Sabinsa has recently published its first human clinical study on anti-acne benefits of LactoSporin®, the probiotic metabolite derived from the highly regarded probiotic LactoSpore®. A second published study, in vitro, demonstrated the anti-aging potential of this topical ingredient. Together, the research supports the use of LactoSporin for skin care applications.
© 2025 Sabinsa. All Rights Reserved | Disclaimer